AstraZeneca Ponders a Huge $240 Billion Gilead Gamble

Most visited

1 year ago full article

share

(Bloomberg Opinion) -- There are good reasons for Britain’s AstraZeneca Plc to consider what would be the biggest pharmaceuticals deal in history by combining with U.S. peer Gilead Sciences Inc. They may not be good enough to offs ...Read More

170o

70%
Menu

Leave a Comment